Cargando…
Halofuginone inhibits TGF-β/BMP signaling and in combination with zoledronic acid enhances inhibition of breast cancer bone metastasis
More efficient therapies that target multiple molecular mechanisms are needed for the treatment of incurable bone metastases. Halofuginone is a plant alkaloid-derivative with antiangiogenic and antiproliferative effects. Here we demonstrate that halofuginone is an effective therapy for the treatment...
Autores principales: | Juárez, Patricia, Fournier, Pierrick G.J., Mohammad, Khalid S., McKenna, Ryan C., Davis, Holly W., Peng, Xiang H., Niewolna, Maria, Mauviel, Alain, Chirgwin, John M., Guise, Theresa A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689697/ https://www.ncbi.nlm.nih.gov/pubmed/29156807 http://dx.doi.org/10.18632/oncotarget.21200 |
Ejemplares similares
-
Hypoxia and TGF-β Drive Breast Cancer Bone Metastases through Parallel Signaling Pathways in Tumor Cells and the Bone Microenvironment
por: Dunn, Lauren K., et al.
Publicado: (2009) -
Tumor-expressed adrenomedullin accelerates breast cancer bone metastasis
por: Siclari, Valerie A, et al.
Publicado: (2014) -
Pharmacologic Inhibition of the TGF-β Type I Receptor Kinase Has Anabolic and Anti-Catabolic Effects on Bone
por: Mohammad, Khalid S., et al.
Publicado: (2009) -
Inhibition of TGF-β signaling with halofuginone can enhance the antitumor effect of irradiation in Lewis lung cancer
por: Lin, Runlong, et al.
Publicado: (2015) -
Halofuginone attenuates osteoarthritis by inhibition of TGF-β activity and H-type vessel formation in subchondral bone
por: Cui, Zhuang, et al.
Publicado: (2016)